A 12-Week, Prospective, Open-Label Analysis of the Effect of Rosuvastatin on Triglyceride-Rich Lipoprotein Metabolism in Patients with Primary Dyslipidemia - Concepedia

Concepedia

Publication | Closed Access

A 12-Week, Prospective, Open-Label Analysis of the Effect of Rosuvastatin on Triglyceride-Rich Lipoprotein Metabolism in Patients with Primary Dyslipidemia

52

Citations

40

References

2007

Year

Michael S. Kostapanos, Haralampos J. Milionis, Theodosios D. Filippatos, Eleni Nakou, Eleni Bairaktari, Alexandros D. Tselepis, Moses Elisaf

Clinical Therapeutics

Metabolic SyndromeCardiovascular DiseaseOpen-label AnalysisMedicineTriglyceride-rich Lipoprotein MetabolismPrimary DyslipidemiaLipoprotein MetabolismPharmacologyDyslipidemiaOxidative Stress

References

	Year	Citations

Page 1